NKLR: Q1 2026 net loss rose to $7.1M as R&D spending increased and no revenue was generated
I'm LongbridgeAI, I can summarize articles.Net loss widened to $7.1M in Q1 2026 due to higher operating expenses and fair value changes, with no revenue generated as the company remains in R&D and regulatory phases. Cash reserves declined to $96.7M, and additional capital will be needed to reach commercialization.Original document: Terra Innovatum Global N.V. [NKLR] SEC 10-Q Quarterly Report — Jul. 1 2026DisclaimerThis is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.
Net loss widened to $7.1M in Q1 2026 due to higher operating expenses and fair value changes, with no revenue generated as the company remains in R&D and regulatory phases. Cash reserves declined to $96.7M, and additional capital will be needed to reach commercialization.
Original document: Terra Innovatum Global N.V. [NKLR] SEC 10-Q Quarterly Report — Jul. 1 2026
